Table 3.
Summary of Chemokines Studies in Serum/Plasma of MDD Patients.
| Study / Year | Chemokines | Findings |
|---|---|---|
| Song et al. (1998) | CXCL8 | Increased |
| Simon el al. (2008) | CXCL8, CCL2, CCL3, CCL11 | Increased |
| Sutcigil et al. (2007) | CCL2 | Increased |
| O’Brien et al. (2007) | CXCL8 | No significant difference |
| Eller et al. (2008) | CXCL8 | No significant difference |
| Wang et al. (2008) | CXCL10 | Increased |
| Musselman et al. (2000) | OC3CL1, CLL3 | Increased |
| Lehto et al. (2010) | CCL2, CCL3 | Decreased |
| Oglodek et al. (2014) | CXCL12, CCL5 | Increased |
| Meta-analyses | ||
| Eyre et al. (2016) | CCL | Increased |
| CXCL8 | No significant difference | |
| Leighton et al. (2018) | CCL2, CCL3, CCL11, CXCL7, CXCL8 | Increased |
| CCL4 | Decreased | |
| CCL5 | No significant difference |